跳至主要内容
临床试验/ACTRN12624000091505
ACTRN12624000091505尚未招募Unknown

PhaRmacogEnomiC medIcines optimiSatIon for peOple with caNcer – a multicentre teletrial enabled Interrupted Time Series trial (PRECISION-ITS): Pharmacogenomics Education & Implementation Program for Pharmacists

Peter MacCallum Cancer Centre0 个研究点目标入组 20 人开始时间: 2024年2月1日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Educational / counselling / training
盲法
Open (masking not used)

入排标准

年龄范围
15 Years 至 o limit(—)
性别
All

入选标准

  • National KAP Survey - Healthcare professionals (adult oncology)
  • 1. Cancer healthcare professional (medical oncologist, haematologist, pharmacist, or nurse)
  • 2. Cares for people with cancer at an Australian hospital, or managers or clinical supervisors of healthcare professionals who care for people with cancer at an Australian hospital
  • 3. English language reading capability to complete surveys
  • National KAP Survey - Consumers (adult oncology)
  • 1. Adults, aged > 18 years
  • 2. Have had treatment for cancer, or cared for a person who has had treatment for cancer in the Australian healthcare system
  • 3. English language reading capability to complete surveys
  • National KAP Survey - Adolescents & Young Adults (AYA) (paediatric oncology)
  • 1. AYA aged > 15 years who have a diagnosis of cancer or immunosuppression
  • 2. Have had treatment for cancer, or cared for a person who has had treatment for cancer in the Australian healthcare system
  • 3. English language reading capability to complete surveys
  • National KAP Survey - Carers (paediatric oncology)
  • 1. Caregiver of a child who has received a diagnosis of cancer or immunosuppression (current or recent)
  • 2. Caregiver of a child who has had treatment for cancer in the Australian healthcare system
  • 3. English language reading capability to complete surveys
  • National KAP Survey - Healthcare professionals (paediatric oncology)
  • 1. Cancer healthcare professional (medical oncologist, haematologist, pharmacist, or nurse)
  • 2. Cares for people with cancer at an Australian hospital, or managers or clinical supervisors of healthcare professionals who care for people with cancer at an Australian hospital
  • 3. English language reading capability to complete surveys
  • Pharmacogenomics Education/Implementation Program:
  • 1. Pharmacists at PRECISION-ITS primary and satellite sites.

排除标准

  • National KAP Survey - Adolescents & Young Adults (AYA) (paediatric oncology)
  • 1. AYA must not be participating in the MARVEL-PIC study (NCT05667766).
  • National KAP Survey - Carers (paediatric oncology)
  • 1. Child of caregiver must not be participating in the MARVEL-PIC study (NCT05667766).

研究者

发起方
Peter MacCallum Cancer Centre

相似试验

尚未招募
Unknown
PhaRmacogEnomiC medIcines optimiSatIon for peOple with caNcer – a multicentre teletrial enabled Interrupted Time Series trial (PRECISION-ITS): Pharmacogenomics primary study and discovery program
ACTRN12624000079549Peter MacCallum Cancer Centre1,470
尚未招募
不适用
PhaRmacogEnomiC medIcines optimiSatIon for peOple with caNcer – a multicentre teletrial enabled Interrupted Time Series trial (PRECISION-ITS): A nested cohort substudy evaluating the safety & efficacy of 5-Fluorouracil Therapeutic Drug Monitoring in patients with metastatic/unresectable colorectal cancer.
ACTRN12624000078550Peter MacCallum Cancer Centre200
已完成
不适用
Pharmacists' review of medicine during admission to hospitalIn-hospital adverse drug eventsOther complications of surgical and medical care, not elsewhere classified
ISRCTN08043800Region Zealand Hospital Pharmacy (Region Sjaelland Sygehusapoteket) (Denmark)648
暂停
不适用
Optimization of the pharmacological component using additive placeboeffects: Is it possible to enhance the psychological component during self-medication by disclosing information about the psychological componentsself-medication: participants using a specific analgesic (ibuprofen, paracetamol, aspirin) for pain relief self-medication: participants using a specific antihistamine (dimetindene, loratadine, cetirizine) for itch relief
DRKS00009506niversitätsklinikum Hamburg-Eppendorf Klinik und Poliklinik für Anästhesiologie108
已完成
不适用
Efficacy of medication optimization protocol for older inpatients: a randomized controlled trialPolypharmacy among older adults
JPRN-UMIN000035265St. Marianna university school of medicine500